Article

Staphylococcus aureus disease and drug resistance in resource-limited countries in South and East Asia

Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
The Lancet Infectious Diseases (Impact Factor: 22.43). 03/2009; 9(2):130-5. DOI: 10.1016/S1473-3099(09)70022-2
Source: PubMed

ABSTRACT

By contrast with high-income countries, Staphylococcus aureus disease ranks low on the public-health agenda in low-income countries. We undertook a literature review of S aureus disease in resource-limited countries in south and east Asia, and found that its neglected status as a developing world pathogen does not equate with low rates of disease. The incidence of the disease seems to be highest in neonates, its range of clinical manifestations is as broad as that seen in other settings, and the mortality rate associated with serious S aureus infection, such as bacteraemia, is as high as 50%. The prevalence of meticillin-resistant S aureus (MRSA) infection across much of resource-limited Asia is largely unknown. Antibiotic drugs are readily and widely available from pharmacists in most parts of Asia, where ease of purchase and frequent self-medication are likely to be major drivers in the emergence of drug resistance. In our global culture, the epidemiology of important drug-resistant pathogens in resource-limited countries is inextricably linked with the health of both developing and developed communities. An initiative is needed to raise the profile of S aureus disease in developing countries, and to define a programme of research to find practical solutions to the health-care challenges posed by this important global pathogen.

Download full-text

Full-text

Available from: Eoin West, Jan 16, 2014
  • Source
    • "In the developing world, mortality associated with severe Staphylococcus aureus infections far exceeds that in developed countries (Nickerson et al., 2009a; 2009b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Infections with Staphylococcus aureus, a versatile human pathogen have continued to raise concerns particularly in hospital setting resulting in high rates of morbidity and mortality. For proper and adequate infection control and treatment in our environment, it has become necessary to determine the prevalence and antibiotic sensitivity profile of the organism. A total of 100 clinical specimens were collected from outpatients who visited hospitals in Anyigba. The samples were screened for Staphylococcus aureus by standard bacteriological procedures. Antibiotic sensitivity was determined by disc diffusion method. A total of 84 Staphylococcus aureus isolates were identified in this study. Females (61.9%) had a higher infection rate. Those within age group 0-10 years were most affected. Isolates were susceptible to Gentamicin (100%), Ofloxacin (81.8%), Ciprofloxacin (72.7%), Streptomycin (72.7%) and Erythromycin (63.6%). Eleven Methicillin Resistant Staphylococcus aureus (MRSA) isolates were identified by disc diffusion technique using Oxacillin. Fifty four percent of the isolates were resistant to Erythromycin and Amoxicillin/Clavulanate respectively. The study highlights the need for periodic surveillance of MRSA for effective infection control. © 2015 Charles Kehinde Mofolorunsho, Monday Ocheni, Cornelius Arome Omatola and Ashem Godwin Agieni.
    Full-text · Article · Apr 2015 · American journal of infectious diseases
  • Source
    • "Antimicrobial resistance in resourcepoor settings is fueled by weak control of antibiotic prescribing and stewardship both in the community and hospitals, and by weak infection control infrastructure that fails to prevent the transmission of nosocomial pathogens—many of which are multidrug resistant. Methicillin-resistant Staphylococcus aureus (MRSA) is a leading nosocomial pathogen worldwide (Nickerson et al. 2009a, b; Falagas et al. 2013). MRSA carriage in the community remains low in many countries, and healthcare-associated infection is often associated with acquisition within a healthcare setting. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infection. Whole-genome sequencing of MRSA has been used to define phylogeny and transmission in well-resourced healthcare settings, yet the greatest burden of nosocomial infection occurs in resource-restricted settings where barriers to transmission are lower. Here, we study the flux and genetic diversity of MRSA on ward and individual patient levels in a hospital where transmission was common. We repeatedly screened all patients on two intensive care units for MRSA carriage over a 3-mo period. All MRSA belonged to multilocus sequence type 239 (ST 239). We defined the population structure and charted the spread of MRSA by sequencing 79 isolates from 46 patients and five members of staff, including the first MRSA-positive screen isolates and up to two repeat isolates where available. Phylogenetic analysis identified a flux of distinct ST 239 clades over time in each intensive care unit. In total, five main clades were identified, which varied in the carriage of plasmids encoding antiseptic and antimicrobial resistance determinants. Sequence data confirmed intra- and interwards transmission events and identified individual patients who were colonized by more than one clade. One patient on each unit was the source of numerous transmission events, and deep sampling of one of these cases demonstrated colonization with a "cloud" of related MRSA variants. The application of whole-genome sequencing and analysis provides novel insights into the transmission of MRSA in under-resourced healthcare settings and has relevance to wider global health. © 2015 Tong et al.; Published by Cold Spring Harbor Laboratory Press.
    Full-text · Article · Dec 2014 · Genome Research
  • Source
    • "). Methicillin resistant S. aureus (MRSA) has become a major public health problem worldwide (Jarvis et al., 2007). In the developing world, mortality associated with severe S. aureus infections far exceeds that in developed countries (Nickerson et al., 2009). Recent studies have identified S. aureus as the main etiological agent of many infections in sub-Saharan Africa (Nantanda et al., 2008). "

    Full-text · Article · Jan 2014
Show more